A citation-based method for searching scientific literature

Helga Bergholtz, Tonje G Lien, David M Swanson, Arnoldo Frigessi, Maria Grazia Daidone, Jörg Tost, Fredrik Wärnberg, Therese Sørlie. NPJ Breast Cancer 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Takamaru Ashikaga, Donald L Weaver, Barbara J Miller, Lynne M Jalovec, Thomas G Frazier,[...]. Lancet Oncol 2007
622
100

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
Erik von Elm, Douglas G Altman, Matthias Egger, Stuart J Pocock, Peter C Gøtzsche, Jan P Vandenbroucke. Int J Surg 2014
100

The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation.
Richard N Shiffman, Jane Dixon, Cynthia Brandt, Abdelwaheb Essaihi, Allen Hsiao, George Michel, Ryan O'Connell. BMC Med Inform Decis Mak 2005
199
100

Sentinel lymph node biopsy is feasible even after total mastectomy.
Mattia Intra, Paolo Veronesi, Oreste D Gentilini, Giuseppe Trifirò, Anastasio Berrettini, Rafaela Cecilio, Marco Colleoni, Mario Rietjens, Alberto Luini, Giovanni Paganelli,[...]. J Surg Oncol 2007
18
100

Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
Tawakalitu O Oseni, Barbara L Smith, Constance D Lehman, Charmi A Vijapura, Niveditha Pinnamaneni, Manisha Bahl. Ann Surg Oncol 2020
4
100


STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.
Patrick M Bossuyt, Johannes B Reitsma, David E Bruns, Constantine A Gatsonis, Paul P Glasziou, Les Irwig, Jeroen G Lijmer, David Moher, Drummond Rennie, Henrica C W de Vet,[...]. BMJ 2015
100

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
32
100

Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Grace Clarke Hillyer, Ling Chen, Dawn L Hershman. Breast Cancer Res Treat 2016
11
100


Risk of death from breast cancer after treatment for ductal carcinoma in situ.
C Wadsten, H Garmo, I Fredriksson, M Sund, F Wärnberg. Br J Surg 2017
14
100

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.
Brigid K Killelea, Jessica B Long, Weixiong Dang, Sarah S Mougalian, Suzanne B Evans, Cary P Gross, Shi-Yi Wang. Ann Surg Oncol 2018
16
100

DCIS and axillary nodal evaluation: compliance with national guidelines.
Katrina B Mitchell, Heather Lin, Yu Shen, Alfred Colfry, Henry Kuerer, Simona F Shaitelman, Gildy V Babiera, Isabelle Bedrosian. BMC Surg 2017
22
100

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
450
100


Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
38
100

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, I T Rubio, S Zackrisson, E Senkus. Ann Oncol 2019
287
100

The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines.
Melissa C Brouwers, Kate Kerkvliet, Karen Spithoff. BMJ 2016
204
100

Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.
Hiba El Hage Chehade, Hannah Headon, Umar Wazir, Houssam Abtar, Abdul Kasem, Kefah Mokbel. Am J Surg 2017
20
100

A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.
Yaolong Chen, Kehu Yang, Ana Marušic, Amir Qaseem, Joerg J Meerpohl, Signe Flottorp, Elie A Akl, Holger J Schünemann, Edwin S Y Chan, Yngve Falck-Ytter,[...]. Ann Intern Med 2017
174
100

Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
Melissa Pilewskie, Maria Karsten, Julia Radosa, Anne Eaton, Tari A King. Ann Surg Oncol 2016
6
100

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.
Gurdeep S Mannu, Emma J Groen, Zhe Wang, Michael Schaapveld, Esther H Lips, Monica Chung, Ires Joore, Flora E van Leeuwen, Hendrik J Teertstra, Gonneke A O Winter-Warnars,[...]. Breast Cancer Res Treat 2019
9
100

Development of the AGREE II, part 2: assessment of validity of items and tools to support application.
Melissa C Brouwers, Michelle E Kho, George P Browman, Jako S Burgers, Françoise Cluzeau, Gene Feder, Béatrice Fervers, Ian D Graham, Steven E Hanna, Julie Makarski. CMAJ 2010
263
100

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
161
100

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Ling Chen, Dawn L Hershman. JAMA Oncol 2015
15
100

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
45
100

Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
Michael R Harowicz, Ashirbani Saha, Lars J Grimm, P Kelly Marcom, Jeffrey R Marks, E Shelley Hwang, Maciej A Mazurowski. J Magn Reson Imaging 2017
10
100

Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates.
Angelena Crown, Debra G Wechter, Janie W Grumley. Ann Surg Oncol 2015
39
100

Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ.
A Fancellu, R M Turner, J M Dixon, A Pinna, P Cottu, N Houssami. Br J Surg 2015
55
100


Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.
S M Feldman, D N Krag, R K McNally, B B Moor, D L Weaver, P Klein. J Am Coll Surg 1999
122
100


Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision.
F Celebioglu, J Frisell, R Danielsson, L Bergkvist. Eur J Surg Oncol 2007
14
100

Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Carina Strell, Janna Paulsson, Shao-Bo Jin, Nicholas P Tobin, Artur Mezheyeuski, Pernilla Roswall, Ceren Mutgan, Nicholas Mitsios, Hemming Johansson, Sarah Marie Wickberg,[...]. J Natl Cancer Inst 2019
33
100

Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
Michael J Campbell, Frederick Baehner, Tess O'Meara, Ekene Ojukwu, Booyeon Han, Rita Mukhtar, Vickram Tandon, Max Endicott, Zelos Zhu, Jasmine Wong,[...]. Breast Cancer Res Treat 2017
53
100

Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
Hideo Shigematsu, Takayuki Kadoya, Norio Masumoto, Kazuo Matsuura, Akiko Emi, Keiko Kajitani, Ai Amioka, Morihito Okada. Clin Breast Cancer 2014
10
100

The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov. Eur J Cancer 2017
11
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.